New Synthetic Molecules Trigger Immune Response to HIV and Prostate Cancer

November 5, 2009
New Synthetic Molecules Trigger Immune Response to HIV and Prostate Cancer

Enlarge

(PhysOrg.com) -- Researchers at Yale University have developed synthetic molecules capable of enhancing the body’s immune response to HIV and HIV-infected cells, as well as to prostate cancer cells. Their findings, published online in the Journal of the American Chemical Society, could lead to novel therapeutic approaches for these diseases.

The — called “antibody-recruiting molecule targeting HIV” (ARM-H) and “antibody-recruiting molecule targeting prostate cancer” (ARM-P) — work by binding simultaneously to an antibody already present in the bloodstream and to proteins on HIV, HIV-infected cells and cancer cells. By coating these pathogens in , the molecules flag them as a threat and trigger the body’s own . In the case of ARM-H, by binding to proteins on the outside of the virus, they also prevent healthy human cells from being infected.

“Instead of trying to kill the pathogens directly, these molecules manipulate our to do something it wouldn’t ordinarily do,” said David Spiegel, M.D., assistant professor of chemistry and the corresponding author of both papers.

Because both HIV and cancer have methods for evading the body’s immune system, treatments and vaccinations for the two diseases have proven difficult. Current treatment options for HIV and prostate cancer — including antiviral drugs, radiation and chemotherapy — involve severe side effects and are often ineffective against advanced cases. While there are some antibody drugs available, they are difficult to produce in large quantities and are costly. They also must be injected and are accompanied by severe side effects of their own.

By contrast, the ARM-H and ARM-P molecules, which the team has begun testing in mice, are structurally simple, inexpensive to produce, and could in theory be taken in pill form, Spiegel said. And because they are unlikely to target essential biological processes in the body, the side effects could be smaller, he noted.

“This is an entirely new approach to treating these two diseases, which are extraordinarily important in terms of their impact on human health,” Spiegel said.

HIV is a global pandemic that affects 33 million people worldwide, while is the second leading cause of cancer-related death among American men, with one out of every six American men expected to develop the disease.

Provided by Yale University (news : web)

4.7 /5 (9 votes)  

Rank 4.7 /5 (9 votes)
Related Stories
Relevant PhysicsForums posts
  • How to determine zinc in a plant.
    createdFeb 11, 2012
  • Stoichiometry
    createdFeb 10, 2012
  • Boiling and melting point of impure substances
    createdFeb 10, 2012
  • Safe nitrogen compound to decompose a 500 deg C in a furnace?
    createdFeb 09, 2012
  • [ask]electron inside drinking water
    createdFeb 08, 2012
  • How to avoid formation of Lithium Chromate ???
    createdFeb 08, 2012
  • More from Physics Forums - Chemistry

More news stories

Scientists discover molecular secrets of 2,000-year-old Chinese herbal remedy

For roughly two thousand years, Chinese herbalists have treated Malaria using a root extract, commonly known as Chang Shan, from a type of hydrangea that grows in Tibet and Nepal. More recent studies suggest that halofuginone, ...

Chemistry / Biochemistry

created 45 minutes ago | popularity 5 / 5 (2) | comments 0 | with audio podcast

New method to examine batteries -- MRI from the inside

There is an ever-increasing need for advanced batteries for portable electronics, such as phones, cameras, and music players, but also to power electric vehicles and to facilitate the distribution and storage of energy derived ...

Chemistry / Analytical Chemistry

created 45 minutes ago | popularity 5 / 5 (1) | comments 0 | with audio podcast

Hydrogen from acidic water: Researchers develop potential low cost alternative to platinum for splitting water

A technique for creating a new molecule that structurally and chemically replicates the active part of the widely used industrial catalyst molybdenite has been developed by researchers with the Lawrence Berkeley ...

Chemistry / Materials Science

created Feb 09, 2012 | popularity 4.8 / 5 (16) | comments 21 | with audio podcast

Fool's gold may prove an unlikely alternative to overexploited catalytic materials

Catalytic materials, which lower the energy barriers for chemical reactions, are used in everything from the commercial production of chemicals to catalytic converters in car engines. However, with current catalytic materials ...

Chemistry / Materials Science

created Feb 10, 2012 | popularity 4.4 / 5 (8) | comments 8 | with audio podcast

Research provides octagonal window of opportunity for carbon capture

(PhysOrg.com) -- Filtering carbon dioxide, a greenhouse gas, from factory smokestacks is a necessary, but expensive part of many manufacturing processes. However, a collaborative research team from the National ...

Chemistry / Materials Science

created Feb 08, 2012 | popularity 5 / 5 (2) | comments 5 | with audio podcast


A mitosis mystery solved: How chromosomes align perfectly in a dividing cell

Although the process of mitotic cell division has been studied intensely for more than 50 years, Whitehead Institute researchers have only now solved the mystery of how cells correctly align their chromosomes during symmetric ...

Starve a virus, feed a cure? Findings show how some cells protect themselves against HIV

A protein that protects some of our immune cells from the most common and virulent form of HIV works by starving the virus of the molecular building blocks that it needs to replicate, according to research published online ...

Researchers find extensive RNA editing in human transcriptome

In a new study published online in Nature Biotechnology, researchers from BGI, the world's largest genomics organization, reported the evidence of extensive RNA editing in a human cell line by analysis of RNA-seq data, demons ...

The proteins ensuring genome protection

Researchers from the University of Geneva (UNIGE), Switzerland, have discovered the crucial role of two proteins in developing a cell 'anti-enzyme shield'. This protection system, which operates at the level of molecular ...

Lab study raises questions over nano-particle impact

Tests involving chickens have raised questions about the impact on health from engineered nano-particles, the ultra-fine grains commonly used in drugs and processed foods, scientists said on Sunday.

Iran blocks email, restricts net access: reports

Iran has further restricted access to the Internet and blocked popular email services for the past few days, in a move a top lawmaker said could "cost the regime dearly," media reports said on Sunday.